Lattice Biologics, Ltd. is a biotech company. The company is headquartered in Belgrade Montana, Montana. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.
LBLTF stock price ended at $0 on 水曜日, after rising NaN%
On the latest trading day Dec 03, 2025, the stock price of LBLTF rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 12.6K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 25.0K shares were traded, equating to a market value of approximately --.